Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma

INTRODUCTION: BRAF V600E and V600K melanomas have distinct clinicopathologic features, and V600K appear to be less responsive to BRAFi+/−MEKi. We investigated mechanisms for this and explored whether genotype affects response to immunotherapy. METHODS: Pre-treatment formalin-fixed paraffin-embedded...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: da Silva, Inês Pires, Wang, Kevin YX, Wilmott, James S, Holst, Jeff, Carlino, Matteo S, Park, John J, Quek, Camelia, Wongchenko, Matthew, Yan, Yibing, Mann, Graham, Johnson, Douglas B., McQuade, Jennifer L, Rai, Rajat, Kefford, Richard F, Rizos, Helen, Scolyer, Richard A, Yang, Jean YU, Long, Georgina V, Menzies, Alexander M
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7015248/
https://ncbi.nlm.nih.gov/pubmed/30630828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-1680
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados